TITLE

A New Technique in the Treatment of Thromboembolic Stoke Preliminary Report

AUTHOR(S)
Leon-Sotomayor, Luis
PUB. DATE
November 1980
SOURCE
Angiology;Nov1980, Vol. 31 Issue 11, p729
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses about a new technique in the treatment of thromboembolic stoke. A rational therapeutic approach using the intracarotid injection technique for the treatment of thromboembolic stroke is described in 35 patients. The modality consists of sequential intracarotid injection of heparin, saline, a solution of Dextran 40-20% Mannitol-vasodilator-glucose and steroid. Epidemologic survey of cerebrovascular disease indicates that 80% of stroke victims required initial hospitalization during the 2-year period of 1975 and 1976.'" The morbidity is high and the cost of care staggering.
ACCESSION #
16389978

 

Related Articles

  • The new contract: Stroke and TIAs. Jenkinson, Damian // GP: General Practitioner;9/29/2003, p59 

    This article presents information on the management of stroke and TIAs. ACE inhibitors and diuretics can lead to reduction in recurrent stroke. Anticoagulating patients in AF can reduce risk of stroke by 68 percent. Thirty-one of the clinical quality points in the new contract relate to the...

  • Medications may help decrease stroke risk after a TIA.  // Mayo Clinic Health Letter;Nov2000, Vol. 18 Issue 11, p5 

    Provides information pertaining to two frequently prescribed types of drugs to decrease the likelihood of a stroke following a transient ischemic attack. Antiplatelet drugs; Anticoagulants.

  • Stroke care specialist makes case for emergency warfarin-reversal protocol. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;4/1/2007, Vol. 64 Issue 7, p678 

    The article discusses the need for hospitals with a protocol for giving a thrombolytic agent to patients immediately after in ischemic stroke to have a written protocol for reversing the anticoagulant effect of warfarin. According to stroke care specialist J. Claude Hemphill III,...

  • Antiplatelet medication management in patients hospitalized with ischemic stroke. Nickman, Nancy A.; Biskupiak, Joseph; Creekmore, Freddy; Shah, Hemal; Brixner, Diana I. // American Journal of Health-System Pharmacy;11/1/2007, Vol. 64 Issue 21, p2250 

    Purpose. The use of antiplatelet agents in patients hospitalized with ischemic stroke was studied. Methods. Patients with a primary or secondary diagnosis of noncardiogenic, thrombotic ischemic stroke from January 2002 through December 2004 were included in the analysis. Patients were then...

  • A clinical prediction rule to identify patients with atrial fibrilation and a low risk for stroke while taking aspirin.  // Current Medical Literature: Stroke Review;2003, Vol. 7 Issue 3, p86 

    Describes the development and internal validation of an age-independent clinical prediction rule to identify patients at low risk of thromboembolism who may be safely managed on aspirin alone. Extraction of data from six previous randomized controlled trials of the use of anticoagulation and...

  • New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation. Hammw�hner, Matthias; D'Alessandro, Alessandra; Wolfram, Oliver; Goette, Andreas // Current Vascular Pharmacology;Jul2007, Vol. 5 Issue 3, p211 

    Atrial fibrillation (AF) is associated with a 6 fold increased risk for ischemic stroke. Observational studies suggest that one in four to five strokes is due to AF. Depending on the risk profile of an individual patient, the yearly risk for ischemic stroke is between 2% and 14%. AF is...

  • INDICATIONS AND CONTRAINDICATIONS OF ANTICOAGULANT THERAPY IN THROMBOEMBOLIC CEREBROVASCULAR DISEASE. McDevitt, Ellen // Angiology;Jan1964, Vol. 15 Issue 1, p17 

    The use of anticoagulants in cerebral vascular disease imposes a grave responsibility on the physician, laboratory and, to a lesser degree, the patient. However, when safeguards outlined above are rigidly observed and the pitfalls are avoided, the administration of these drugs becomes more...

  • Time to try this warfarin alternative? Hickner, John; Rowland, Kate // Clinician Reviews;May2011, Vol. 21 Issue 5, p29 

    The article features the oral anticoagulant dabigatran that is used to prevent stroke and thromboembolism in patients with atrial fibrillation. It is considered as an alternative for warfarin which requires repeated monitoring due to possible occurrences of both major and minor bleeding. Results...

  • Genotype-guided warfarin dosing now a reality. Cooper-DeHoff, Rhonda M.; Pacanowski, Michael A. // Cardiology Today;Feb2008, Vol. 11 Issue 2, p18 

    The article provides information on the use of the drug warfarin. It states that the drug is the most commonly prescribed oral anticoagulant and is effective for treating thromboembolism and stroke. It is noted that optimal warfarin dosage is difficult because of its narrow therapeutic index and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics